Toronto, Ontario--(Newsfile Corp. - September 8, 2023) - PurMinds NeuroPharma ("PurMinds" or the "Company"), a Canadianneuroscience company with a robust clinical pipeline combining small molecules, psychedelic compounds and other modalities, pursuing breakthrough therapeutic solutions for neurological disorders marred by neurodegeneration, today...